Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-19-000849
Filing Date
2019-03-01
Accepted
2019-03-01 17:01:29
Documents
8
Period of Report
2019-03-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2237876zpre14a.htm PRE 14A 998583
2 G1039423.JPG g1039423.jpg GRAPHIC 16435
3 G751951.JPG g751951.jpg GRAPHIC 16543
4 G151688.JPG g151688.jpg GRAPHIC 21601
5 G436184.JPG g436184.jpg GRAPHIC 99005
6 G550440.JPG g550440.jpg GRAPHIC 43758
7 G26402BGI001.GIF g26402bgi001.gif GRAPHIC 227260
8 G26402BGI002.GIF g26402bgi002.gif GRAPHIC 155128
  Complete submission text file 0001047469-19-000849.txt   1798615
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37368 | Film No.: 19650431
SIC: 2836 Biological Products, (No Diagnostic Substances)